Approval · Notice of Compliance 2899 · 1998
SIBELIUM: Notice of Compliance 2899
Issued September 9, 1998
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 2899
- Date
- September 9, 1998
- Company
- Pharmascience Inc.Montreal, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Product monograph changes
- Therapeutic class
- Selective calcium-entry blocker
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| SIBELIUM | Not yet assigned | — |
Medicinal ingredients
- FLUNARIZINE HCL 5 MG per CAP